| Literature DB >> 26330164 |
Hillary G Caruso1, Lenka V Hurton1, Amer Najjar2, David Rushworth1, Sonny Ang2, Simon Olivares2, Tiejuan Mi2, Kirsten Switzer2, Harjeet Singh2, Helen Huls2, Dean A Lee1, Amy B Heimberger3, Richard E Champlin4, Laurence J N Cooper5.
Abstract
Many tumors overexpress tumor-associated antigens relative to normal tissue, such as EGFR. This limits targeting by human T cells modified to express chimeric antigen receptors (CAR) due to potential for deleterious recognition of normal cells. We sought to generate CAR(+) T cells capable of distinguishing malignant from normal cells based on the disparate density of EGFR expression by generating two CARs from monoclonal antibodies that differ in affinity. T cells with low-affinity nimotuzumab-CAR selectively targeted cells overexpressing EGFR, but exhibited diminished effector function as the density of EGFR decreased. In contrast, the activation of T cells bearing high-affinity cetuximab-CAR was not affected by the density of EGFR. In summary, we describe the generation of CARs able to tune T-cell activity to the level of EGFR expression in which a CAR with reduced affinity enabled T cells to distinguish malignant from nonmalignant cells. ©2015 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26330164 PMCID: PMC4624228 DOI: 10.1158/0008-5472.CAN-15-0139
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701